Oct 18, 2019, 01:00 by admin admin

ASAM applauds a provision of the Reversing the Youth Tobacco Epidemic Act that would ban menthol cigarettes, observing that menthol cigarettes are uniquely attractive to youth.

Oct 17, 2019, 01:00 by admin admin

ASAM mourns the loss of the longtime Maryland Congressman who was a tireless advocate for the people he served and a true champion for expanding access to addiction treatment and recovery in the US.

Oct 3, 2019, 01:00 by admin admin

The American Society of Addiction Medicine (ASAM) and 28 of its chapters –– sent a letter to Senate Majority Leader Mitch McConnell and Senator Minority Leader Chuck Schumer urging the US Senate to pass swiftly comprehensive legislation to address the opioid overdose epidemic.

Sep 27, 2019, 01:00 by admin admin

ASAM sent a letter urging members of Congress to support the Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act), which would place significant restrictions upon flavored tobacco products.

Sep 27, 2019, 01:00 by admin admin

ASAM submitted comments on a Notice of Proposed Rulemaking (NPRM) regarding Confidentiality of Substance Use Disorder Patient Records which would expand the ability of law enforcement to access records protected by 42 CFR Part 2.

Sep 27, 2019, 01:00 by admin admin

ASAM submitted its comments on SAMHSA's NPRM Regarding Confidentiality of Substance Use Disorder Patient Records, which would make significant regulatory changes to 42 CFR Part 2

Sep 27, 2019, 01:00 by admin admin

ASAM joined 47 other organizations in urging Congress to oppose the Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019, which would exempt certain tobacco products from FDA regulation

Sep 27, 2019, 01:00 by admin admin

ASAM submitted its comments on the 2020 Medicare Physician Fee Schedule proposed rule, which focus on the two newly proposed payment bundles for the treatment of opioid use disorder, and a provision of the proposed rule that would permit CMS to revoke or deny Medicare enrollment for physicians and eligible professionals under certain circumstances.

Sep 17, 2019, 01:00 by admin admin

Physician leaders and other clinicians from the American Society of Addiction Medicine ASAM converged on Capitol Hill today to call on members of Congress to take bold, swift steps to reverse the course of the addiction and overdose crisis in the US by supporting key legislation that would close the gap in teaching, standardizing and covering addiction medicine.

Sep 9, 2019, 01:00 by admin admin

ASAM endorses the American College of Medical Toxicology's position statement "Buprenorphine Administration in the Emergency Department."

Sep 5, 2019, 01:00 by admin admin

ASAM and members of the Coalition to Stop Opioid Overdose submitted a letter in support of H.R. 3925, the Reducing Barriers to Substance Use Treatment Act.

Sep 4, 2019, 01:00 by admin admin

The Partnership to Amend 42 CFR Part 2 (of which ASAM is a member) submitted comments to the Office of the National Coordinator for Health Information Technology on the draft Strategy on Reducing Regulatory and Administrative Burden Relating to the Use of Health IT and EHRs.

Aug 29, 2019, 01:00 by admin admin

ASAM urges Congress to make significant improvements to MACRA.

Aug 29, 2019, 01:00 by admin admin

ASAM joined members of the Tobacco Partners Coalition in sending a letter responding to a request for comment on an FDA draft guidance on certain deemed tobacco products

Aug 29, 2019, 01:00 by admin admin

ASAM joined the Partnership to Amend 42 CFR Part 2 in expressing appreciation for SAMHSA's issuance of a notice of proposed rulemaking to modify 42 CFR Part 2, the regulations that govern confidentiality of drug and alcohol treatment and prevention records.

Aug 9, 2019, 01:00 by admin admin

When a patient seeks mental health care or treatment for a substance use disorder, the law makes clear that health insurers and regulators have legal obligations to ensure patients’ access to non-discriminatory care. We are very pleased that the Parity@10 Compliance Campaign will be taking an in-depth look at the significant challenges and barriers to care patients face when seeking treatment.

Aug 9, 2019, 01:00 by admin admin

ASAM, working with the Partnership to Amend 42 CFR PArt 2, sent a letter urging lawmakers to align 42 CFR Part 2 with the Health Insurance Portability and Accountability Act (HIPAA)

Aug 9, 2019, 01:00 by admin admin

In the wake of the introduction of the Overdose Prevention and Patient Safety (OPPS) Act, a bill that would amend the federal statute underlying the addiction treatment privacy regulations known as 42 CFR Part 2 (“Part 2”), ASAM has received many questions about our support for the bill and our position on changing Part 2.

Aug 9, 2019, 01:00 by admin admin

ASAM submitted a comment letter to the Department of Health and Human Services’ Assistant Secretary for Planning and Evaluation (ASPE) in response to an RFI required by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

Aug 9, 2019, 01:00 by admin admin

ASAM, in collaboration with the AMA and APA published an “Enhanced Attestation” form that payers and regulators can use to increase compliance with the Mental Health Parity and Addiction Equity Act (MHPAEA).